Expression and significance of hypoxemia-inducible factor-1α in osteosarcoma of the jaws

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 106, Issue 2, 2008, Pages 254-257

  Chen, Wei liang ^a   Feng, Hong jie ^b   Li, Hai gang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHILD; FEMALE; FIBROUS DYSPLASIA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; JAW DISEASE; JAW TUMOR; MALE; METASTASIS; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); OSTEOSARCOMA; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL RATE; TUMOR RECURRENCE; VASCULARIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA OF BONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JAW DISEASES; JAW NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; SURVIVAL RATE;

EID: 47249157576     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.01.029     Document Type: Article

References (14)

1. Zhang Z.Y. Oral and maxillofacial tumors (2004), Shandong Science and Technology, Jinan, China p. 367
2. Yang Q.C., Zeng B.F., Dong Y., Shi Z.M., Jiang Z.M., and Huang J. Overexpression of hypoxia-inducible factor-1{alpha} in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol 37 (2007) 127-134
3. Enneking W.F., Spanier S.S., and Goodman M.A. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153 (1980) 106-120
4. Zagzag D., Zhong H., Scalzitti J.M., Laughner E., Simons J.W., Semenza G.L., et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88 (2000) 2606-2618
5. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147 (1995) 9-19
6. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
7. Zhang H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 (1999) 5830-5835
8. Birner P., Gatterbauer B., Oberhuber G., Schindl M., Rossler K., Prodinger A., et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92 (2001) 165-171
9. Bos R., Van der Groep P., Greijer A.E., Shvarts A., Meijer S., Pinedo H.M., et al. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97 (2003) 1573-1581
10. Koukourakis M.L., Giatromanolaki A., Sivridis E., Simopoulos C., Turley H., Talks K., et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 1192-1202
11. Kerbel R.S. New targets, drugs, and approaches for the treatment of cancer: an overview. Cancer Metastasis Rev 17 (1998) 145-147
12. Birner P., Pchindl M., Obermair A., Plank C., Breitenecker G., and Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60 17 (2000) 4693-4696
13. Kurokawa T., Miyamoto M., Kato K., Cho Y., Kawarada Y., Hida Y., et al. Overexpression of hypoxia-inducible factor 1alpha (HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 89 (2003) 1042-1047
14. Yang Q.C., Zeng B.F., Shi Z.M., Dong Y., Jiang Z.M., Huang J., et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. J Exp Clin Cancer Res 25 (2006) 593-599